Work

Cardiovascular Outcomes With an Inhaled Long-acting Beta Agonist and Corticosteroid in Patients With Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk: the Summit Trial

Year: 2016

Type: article

Source: Journal of the American College of Cardiology

DOI: 10.1016/s0735-1097(16)31918-0

Authors: Robert D. Brook, Julie Anderson, Peter Calverley, Bartolome Celli, Courtney Crim, Martin Denvir, Sheldon Magder, Fernando Martinez, Sanjay Rajagopalan, Joergen Vestbo, Julie Yates, David Newby

Institution: GlaxoSmithKline (United Kingdom)

Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2318595899

FWCI:

Cites:

Cited by: 1

Related to: 10